IBD Flashcards

1
Q

IBD - PRICMCP?

A

P: dx date, symptoms: diarhoea, PR bleed, mucus, abdo pain, weight loss, obstruction.

Extraintestinal: skin (PG/EN), eye (conjunc/uveitis), joints (arthritis), liver (PSC, cirrhosis)

R: Smoking, FH IBD, GI infections

I: What is the extent of disease? - colonoscopy (maximal extent), if Crohn’s - gastroscopy, SB enterography (or CTE), fistulogram, EUA. Is patient on IBD colonoscopic surveillance?

C: check compliance then complications

UC: toxic megacolon, perforation, massive haemorhage, strictures, CRC

CD: fistulating disease, perianal abscess, SBO, gall stones, malabsorption, GI cancer

Extra-intestinal: VTE (ATIII def)

Complications of drugs: steroids, AZA/6-MP/TNFa sideFx

M: 5-ASA, AZA/6-MP/MTX, steroids, biologics. Any surgeries (colectomy, strictuloplasty, dilatation, EUA, seton). Cessation of smoking.

C: current symptoms (BO frequency, bleeding, pain…etc), frequency of FU, latest colonoscpy or SB imaging, no. of flare up last 12 months

Prognosis & insight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the DDx for colitis (7)?

A
  • Infectious colitis
  • Microscopic (collagenous / lymphocytic) colitis – tx with budesonide
  • IBD
  • Ischaemic colitis
  • Radiation enteritis / proctitis / colitis
  • Diversion colitis
  • Toxic exposure (e.g. peroxide or gold)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is your approach for investigating this patient with suspected IBD?

A

•T: Colonoscopy – macroscopic / microscopic diagnosis, Ab testing

  • UC: cryptitis and crypt abscess. Continuous. pANCA +ve, ASCA -ve
  • Crohn’s – granulomas. Skip lesions. pANCA –ve, ASCA +ve (specific, not sens)

•Exclude infection

  • stool culture, viral PCR, ova, cyst and parasites, c.diff Ag and toxin genes
  • If MSM → syphilis serology. Young – gonorrhoea + chlamydia rectal swab (PCR/NAAT)
  • Immunocompromised: CMV, HSV serology, cryptosporidium, IGRA (CXR too)

•S: Hb (anaemia), inflammatory (WCC, CRP, ESR), AXR – bowel wall thickening (oedena), toxic mega colon, obstruction; MRE or CT

•T: as treatment baseline

  • FBC, EUC, LFTs mainly
  • AZA/6MP: HCV (ab), HBV (sAg, cAb), HIV, VZV, EBV*, TPMT*
  • Anti-TNF/Biologics: above + CXR and IGRA

•S: screen complications

  • Stricturing / fistulating Crohn’s (CT/MR fistulogram or EUA)
  • CRC
  • Mal-absorption
  • Drug toxicity: AZA (pancreatitis), infection (all immSx / biologics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is your approach in managing patients who is on AZA/6MP not responding to treatment?

A
  • Check compliance
  • Thiopurine metabolites – key
  • If absent 6-TGN + 6-MMP → non-compliance
  • If low 6-TGN + 6-MMP both low → sub-therapeutic → ↑dose
  • If high 6-MMP + low 6-TGN → thiopurine resistance → allopurinol
  • If both therapeutic → need another drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain 6-MP/AZA metabolism pathways. What is the mechanism for BM toxicity and Hepatotoxicity?

A
  • AZA/6MP gets metabolised by 1 of the 3 enzymes that are in competition.
  • Metabolism by TPMT produces 6-MMP: inactive form and responsible for hepatotoxicity (>5,700)
  • Metabolism by XO produces 6-TA (inactive)
  • Metabolism by HPRT produces the active form, 6-TGNIf level too high (>235): bone marrow toxicity, as it impairs purine synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What constitute a severe UC in (Truelove-Whitt’s criteria)? (6)

A

BO >= 6/day (Fulminant if >10)

PR bleeding (+++)

Tachycardia (>90)

Temp (>37.5)

Abdominal tenderness

ESR >30, CRP >30, Anaemia <100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Management of acute flare up of UC? (6)

A

Immediate Mx

  • IV fluids
  • IV K+ and Mg+ depending on serum levels (hypo-K is common with diarrhoea + steroids due to MR action)
  • IV steroids
  • DVT prophylaxis
  • Oral Vitamin D
  • Topical mesalazine + steroids if tolerated

Follow-up

  • At least BD review
  • Early surgical review + stoma nurse (provide info pack)
  • Daily AXR

•Stool chart

  • Stool culture to exclude infection
  • Consider unprepared limited flexi-sig → 2 biopsies to exclude CMV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute severe UC - initial IV Hydrocortisone - Still not responding (3 days) – what would you do?

A
  • Consider 2nd line therapy (IFX or Cyclosporin)
  • Discuss the need for colectomy (if no/worsening disease by day 3-5)
  • If IFX or Cyclosporin started – daily bloods, AXR, BD review…etc. If no response by day 7 or curtailed response by day 10 → Surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management for mild-mod UC?

A

Oral 5-ASA

Topical 5-ASA

If repeated episodes of flare - AZA/6MP

Index colonoscopy & determine surveillance frequency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Side effects of

Mesalazine

Olsalazine

Sulfasalazine (4)?

A

Mesalazine - minimal

Olsalazine - can worsen diarrhoea in active UC so only use as maintenance

Sulfasalazine: SJS, reversible male infertility, haemolytic anaemia, folate deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side effects of Azathioprine/6-MP (5)

A

Pancreatitis

Hepatotoxicity

BM toxicity (dose dependent)

Lymphoma risk (hence EBV serology)

Arthritis/Rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the options for thiopurine refractory / steroid dependent/refractory UC?

A
  • Anti-TNFs
  • Vedolizumab (Entyvio) – integrin 𝛼4𝛽7 inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Colectomy – would it cure extraintestinal manifestations?

A

•NO. Ank Spond, liver disease, PG do not improve.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is IPAA and what are the problems (2)?

A
  • Ileal Pouch Anal Anastomosis (pan-proctocolectomy instead of ileostomy) – does give you intestinal continuity
  • Problems = pouchitis (50% - Mx with Metronidazole), BO frequency norm is 4-8 times / day, minor incontinence in 20%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AZA/6MP/MTX and Anti-TNFs are currently used for Crohn’s. Things to check before starting (work-up)

A

General

  • Baseline FBC, EUC, LFTS
  • Hep B, C, EBV (due to lymphoma risk in sero-ves), VZV, HIV
  • Update immunisations
  • Papsmear

Specific

  • AZA/6-MP: TPMT
  • MTX: start folic acid
  • Anti-TNFs: IGRA, CXR (TB), Anti-ds DNA and ANA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A
17
Q

So how would you monitor for patient who you’ve started AZA/6MP?

A

FBC

  • 1st month: weekly
  • 2nd month: 2 weekly
  • 3rd month: 4 weekly to continue

LFTs - Monthly

Clinical examination regularly for lymphadenopathy and skin Ca

Safe to continue in pregnancy

18
Q

What are the side effects of MTX and how would you monitor?

A
  • Hepatotoxicity
  • BM suppression
  • Interstitial pneumonitis
  • C.I in pregnancy (men and women – conception)

Needs

  • Monthly LFTs for 3 months then 3 monthly thereafter
  • If LFTS ≥50% over 1 year → consider liver biopsy
  • 3-6 monthly clinical exam for ILD
19
Q

What are the side effects of Anti-TNFs and how would you monitor? (7)

A
  • Infusion reactions (IFX, monitored in hospital – stop and re-start at slower rate with careful monitoring)
  • Neutropaenia
  • Infections
  • Lymphoma (especially Hepato-Splenic T-cell lymphoma)
  • Demyelinating disease
  • HF
  • Skin rashes (psoriasis like)

Monitoring is therefore (6 monthly review for…)

  • Cardio + Resp exam: HF
  • Abdo exam: Lymphadenopathy, HepatoSplenic T-cell lymphoma
  • Neuro exam: demyelination + consider NCS
  • Skin exam for Rashes and Skin Ca
  • Look for infections
  • Bloods for neutropaenia
  • Pregnancy counselling (probably safe)
20
Q

What are pharmacological options for Crohn’s disease – colonic disease

A
  • Exclude abscess – if present radiological/surgical drainage + Abx for 2-4 weeks
  • Assess disease severity and extent
  • Proctitis: mesalazine suppository + oral 5-ASA (if ≥moderate)
  • Left sided: as above + steroids if severe

Extensive

  • Quiescent: no treatment
  • Mild: steroids (budesonide only if proximal colonic disease) + immunomodulator
  • Moderate / severe: add anti-TNFs, surgery (defunction for symptom control, segmental resection)
21
Q

Pharmacological options for fistulating perianal crohn’s disease?

A
  • Difficult management problem that requires MDT approach with surgeons, AH (dieticians) and physicians
  • Evidence suggest combination therapy with surgical + IFX achieves best outcome and standard of care
  • Exclude sepsis / perianal abscess → Metronidazole, Cipro, surgery
  • EUA + pelvic MRI + fistulogram
  • If simple fistula → seton
  • Complex fistula → surgical (seton?) + Anti-TNF (if luminal activity) +/- allogeneic adipose derived stem cell therapy (if no luminal activity)
22
Q

Mx options for ileocaecal Crohn’s disease?

A
  • Assess severity
  • Exclude infection/abscess
  • ≥Mild disease requires Budesonide or corticoseroids
  • If severe disease → consider surgery (ICR) or anti-TNFs
  • For SB Crohn’s – consider strictuloplasty or SB resection if predominantly fibrotic stricture (indicating long-term damage)
23
Q

Your approach to IBD patients regarding pregnancy?

A
  • Education
  • Folic acid 2mg/day
  • Goal is to minimise active disease (risk factor for LBW, premature delivery, congenital malformation, faetal death if surgery needed)
  • Also majority remain active during pregnancy, 2/3rd will deteriorate
  • Maintenance of remission >> potential adverse effect of medicationContinue taking medications (Except MTX) – includes steroids, MPs, TNFs
  • Mode
  • Close collaboration with Obstetrician is essential
  • Ileostomy/colostomy, no perianal/rectal disease → vaginal
  • Perianal / rectal disease (esp. active) or IPAA → C-section
24
Q

What are other important complications of IBD (general medicine) to be aware of? (8)

A
  • Smoking
  • Malabsorption & nutrition** (healthy diet, dietician)
  • Vitamin D deficiency and Osteoporosis (Vit D, DEXA, OP Mx)
  • Depression & anxiety (regular screening & treat)
  • Thrombotic risk
  • IDA and Anaemia: fatigue → iron transfusion
  • Fertility
  • CRC surveillance